​

Zymeworks (ZYME) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Zymeworks Revenue Highlights

Latest Revenue (Y)

$-27.11M

0

Main Segment (Y)

Milestone Revenue

Zymeworks Revenue by Period

Zymeworks Revenue by Year

DateRevenueChange
2025-12-31$-27.11M-135.53%
2024-12-31$76.30M0.38%
2023-12-31$76.01M-81.57%
2022-12-31$412.48M1446.03%
2021-12-31$26.68M-31.50%
2020-12-31$38.95M31.84%
2019-12-31$29.54M-44.28%
2018-12-31$53.02M2.43%
2017-12-31$51.76M370.18%
2016-12-31$11.01M13.96%
2015-12-31$9.66M478.44%
2014-12-31$1.67M-

Zymeworks generated $-27.11M in revenue during NA 2025, up -135.53% compared to the previous quarter, and up -69.60% compared to the same period a year ago.

Zymeworks Revenue by Quarter

DateRevenueChange
2026-03-31--100.00%
2025-12-31$2.52M-90.89%
2025-09-30$27.61M-43.33%
2025-06-30$48.73M79.73%
2025-03-31$27.11M-12.64%
2024-12-31$31.03M93.94%
2024-09-30$16.00M-16.85%
2024-06-30$19.24M91.85%
2024-03-31$10.03M-40.74%
2023-12-31$16.93M2.54%
2023-09-30$16.51M135.73%
2023-06-30$7.00M-80.32%
2023-03-31$35.58M-91.16%
2022-12-31$402.49M15198.10%
2022-09-30$2.63M-51.65%
2022-06-30$5.44M184.03%
2022-03-31$1.92M-90.36%
2021-12-31$19.87M352.10%
2021-09-30$4.39M148.16%
2021-06-30$1.77M175.00%
2021-03-31$644.00K-95.89%
2020-12-31$15.68M493.27%
2020-09-30$2.64M-78.61%
2020-06-30$12.36M49.46%
2020-03-31$8.27M340.54%
2019-12-31$1.88M-76.12%
2019-09-30$7.86M-0.28%
2019-06-30$7.88M-33.90%
2019-03-31$11.93M-58.77%
2018-12-31$28.93M1308.23%
2018-09-30$2.05M-90.66%
2018-06-30$22.00M54900.00%
2018-03-31$40.00K-99.92%
2017-12-31$50.07M41976.47%
2017-09-30$119.00K-91.13%
2017-06-30$1.34M483.48%
2017-03-31$230.00K-89.70%
2016-12-31$2.23M2.76%
2016-09-30$2.17M-65.76%
2016-06-30$6.34M2320.99%
2016-03-31$262.00K-

Zymeworks generated - in revenue during Q1 2026, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Zymeworks Revenue Breakdown

Zymeworks Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22
Milestone Revenue$25.00M$25.00M--
Research Support Payments And Other Service$5.62M$2.83M$52.62M$8.20M
Option Exercise Fee$7.50M---
Royalty$2.48M$100.00K--
Licensing Fee---$5.00M

Zymeworks's latest annual revenue breakdown by segment (product or service), as of Dec 25: Milestone Revenue (61.58%), Option Exercise Fee (18.47%), Research Support Payments And Other Service (13.83%), and Royalty (6.11%).

Quarterly Revenue by Product

Product/ServiceMar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
Research Support Payments And Other Service$392.00K$352.00K$475.00K$4.49M$764.00K$1.11M$2.07M$10.04M$538.00K$1.16M-----
Royalty$1.33M$831.00K$550.00K$202.00K-----------
Upfront Fee-$18.00M$18.00M$18.00M$18.00M----------
Milestone Revenue--$25.00M$20.00M$14.00M$2.50M$8.00M--------
Option Exercise Fee---$7.50M-----------
Deferred Revenue---$18.33M-----------
License and Service-------------$5.50M-
Milestone Payment-------------$1.00M-
Other Product--------------$2.63M

Zymeworks's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Royalty (77.24%), and Research Support Payments And Other Service (22.76%).

Zymeworks Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BCRXBioCryst Pharmaceuticals$874.84M$159.40M
ARDXArdelyx$407.32M$94.47M
WVEWave Life Sciences$42.73M$38.25M
IMNMImmunome$6.94M-
UPBUpstream Bio$2.85M$1.03M
NTLAIntellia Therapeutics-$15.05M
PHVSPharvaris--
SYRESpyre Therapeutics--
TRVITrevi Therapeutics--
MAZEMaze Therapeutics--
ZYMEZymeworks$-27.11M-

ZYME Revenue FAQ

What is Zymeworks’s yearly revenue?

Zymeworks's yearly revenue for 2025 was $-27.11M, representing a decrease of -135.53% compared to 2024. The company's yearly revenue for 2024 was $76.3M, representing an increase of 0.38% compared to 2023. ZYME's yearly revenue for 2023 was $76.01M, representing a decrease of -81.57% compared to 2022.

What is Zymeworks’s quarterly revenue?

Zymeworks's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a -100.00% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $2.52M, a -90.89% decrease from the previous quarter (Q3 2025), and a -91.90% decrease year-over-year (Q4 2024). ZYME's quarterly revenue for Q3 2025 was $27.61M, a -43.33% decrease from the previous quarter (Q2 2025), and a 72.59% increase year-over-year (Q3 2024).

What is Zymeworks’s revenue growth rate?

Zymeworks's revenue growth rate for the last 3 years (2023-2025) was -135.67%, and for the last 5 years (2021-2025) was -201.61%.

What are Zymeworks’s revenue streams?

Zymeworks's revenue streams in c 25 are Milestone Revenue, Research Support Payments And Other Service, Option Exercise Fee, and Royalty. Milestone Revenue generated $25M in revenue, accounting 61.58% of the company's total revenue Research Support Payments And Other Service generated $5.62M in revenue, accounting 13.83% of the company's total revenue, up 98.10% year-over-year. Option Exercise Fee generated $7.5M in revenue, accounting 18.47% of the company's total revenue Royalty generated $2.48M in revenue, accounting 6.11% of the company's total revenue, up 2381.00% year-over-year.

What is Zymeworks’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Zymeworks was Milestone Revenue. This segment made a revenue of $25M, representing 61.58% of the company's total revenue.